Treatment of premenopausal women with low bone mineral density.

Current Osteoporosis Reports
Adi Cohen, Elizabeth Shane

Abstract

Interpretation of bone mineral density (BMD) results in premenopausal women is particularly challenging, because the relationship between BMD and fracture risk is not the same as for postmenopausal women. Z scores rather than T scores should be used to define "low BMD" in premenopausal women. The finding of low BMD in a premenopausal woman should prompt an evaluation for secondary causes of bone loss. If a secondary cause is found, management should focus on treatment of this condition. In some cases in which the secondary cause cannot be addressed, such as glucocorticoid therapy or cancer chemotherapy, treatment with a bone-active agent to prevent bone loss should be considered. In women with no fractures and no known secondary cause, low BMD may not signify compromised bone strength. BMD is likely to remain stable in these women, and pharmacologic therapy is rarely justified. Assessment of markers of bone turnover and follow-up bone density measurements can help to identify those with an ongoing process of bone loss that may indicate a higher risk for fracture, and possible need for pharmacologic intervention.

References

Dec 1, 1991·The Journal of Clinical Endocrinology and Metabolism·D K KatzmanR Marcus
Jun 1, 1988·The Journal of Clinical Investigation·S L HuiC C Johnston
Jan 1, 1994·The American Journal of Medicine·L K BachrachR B Moss
Aug 1, 1993·Toxicology and Applied Pharmacology·D H MinskerC P Peter
Jun 23, 1993·JAMA : the Journal of the American Medical Association·M SowersB Hollis
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J PowlesS Ashley
Jan 1, 1996·Clinical Oncology : a Journal of the Royal College of Radiologists·T M IllidgeC W Godden
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P D DelmasA Bremond
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisD Torgerson
Aug 15, 1998·Molecular and Cellular Endocrinology·S NakajimaK Ozono
Oct 3, 1998·JAMA : the Journal of the American Medical Association·J S FinkelsteinR M Neer
Feb 20, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·L J MeltonW M O'Fallon
Dec 22, 1999·The Journal of Clinical Endocrinology and Metabolism·L K BachrachR Marcus
Jan 19, 2000·Archives of Physical Medicine and Rehabilitation·T D LauderG D Davis
Feb 9, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C Tudor-Locke, R S McColl
May 5, 2000·The Cochrane Database of Systematic Reviews·J HomikM Suarez-Almazor
May 5, 2000·The Cochrane Database of Systematic Reviews·A CranneyG Wells
Nov 23, 2000·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·A T SweeneyM F Holick
Mar 10, 2001·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·C A Moreira KulakE Shane
Feb 5, 2002·Archives of Internal Medicine·Fiona WuIan R Reid
May 28, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·W D HosmerW S Browner
Jul 11, 2002·Journal of Pediatric and Adolescent Gynecology·Neville H GoldenI Ronald Shenker
Sep 10, 2002·Seminars in Arthritis and Rheumatism·Pilar PerisJosé Muñoz-Gómez
May 6, 2003·The Journal of Bone and Joint Surgery. British Volume·C A WigderowitzC R Paterson
May 6, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Pipasha N BiswasSaad A W Shakir
May 18, 2004·European Journal of Radiology·Konstantinos N MalizosApostolos H Karantanas
Jun 5, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Anna L MeinRoger I Price
Jun 29, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Aki VainionpääTimo Jämsä
Jul 28, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·E M LewieckiD Hans
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Karen K MillerAnne Klibanski
Sep 10, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Craig F J MunnsFrancis H Glorieux
Mar 12, 2005·Current Rheumatology Reports·E Michael Lewiecki
Mar 15, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Joan LappeRobert Heaney
Mar 17, 2005·The Journal of Clinical Endocrinology and Metabolism·Ghada El-Hajj FuleihanAli Shamseddine
Mar 24, 2005·The Journal of Clinical Endocrinology and Metabolism·Neville H GoldenI Ronald Shenker
Mar 25, 2005·Acta Orthopaedica·Magnus K KarlssonCaroline Karlsson
Jun 3, 2005·Clinical Orthopaedics and Related Research·Leung Kim HungLing Qin

❮ Previous
Next ❯

Citations

Apr 5, 2011·Wiener medizinische Wochenschrift·Janina M PatschPeter Pietschmann
Oct 5, 2013·Current Osteoporosis Reports·Adi Cohen, Elizabeth Shane
Aug 13, 2011·The Journal of Clinical Endocrinology and Metabolism·Adi CohenElizabeth Shane
Jun 12, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S FerrariUNKNOWN IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology
Jun 30, 2009·Expert Opinion on Investigational Drugs·Athanasios D AnastasilakisEvangelos Terpos
Feb 18, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C L ShapiroE Paskett
Jul 16, 2009·Menopause : the Journal of the North American Menopause Society·Hyeong Gon YuShin Yong Moon
Apr 2, 2013·The Journal of Clinical Endocrinology and Metabolism·Adi CohenElizabeth Shane
May 28, 2020·Korean journal of family medicine·Sung-Min KimJieun Song
Sep 12, 2013·Clinical Obstetrics and Gynecology·Alice AbrahamElizabeth Shane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.